- Exchange: Toronto
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Tekmira Pharmaceuticals Corp+ Add to Watchlist
TKM:CN8.6600 CAD 0.2600 2.91%
As of 15:59:15 ET on 12/04/2013.
Company Profile for Tekmira Pharmaceuticals Corp (TKM)
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company. The Company is focused on advancing RNAi therapeutics and providing its lipid nanoparticle delivery technology to its pharmaceutical partners.
Tekmira Pharmaceuticals Corp
Key Executives for Tekmira Pharmaceuticals Corp (TKM)
|Mark J MurrayPresident/CEO||Bruce CousinsExec VP/CFO|
|Ian MaclachlanExec VP/Chief Scientific Offcr||Mark KowalskiSenior VP/Chief Medical Officer|
|Paul BrennanSenior VP:Business Dev||Peter LutwycheSenior VP:Pharmaceutical Dev|
|Diane GardinerVP:Human Resources||Jodi RegtsDir:Investor Relations|
|R Hector Mackay-DunnSecretary|